Sign in
4

Changes in Ownership

Vir Biotechnology, Inc. Filed Acc 0001628280-26-012396

SVP, Chief Accounting Officer sold 1,430 shares at $9.53 ($13,632)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Sabatini Brent SVP, Chief Accounting Officer 2026-02-24 Sale 10b5-1 −1,430 $9.53 $13,632 69,613 D
Open-market sales · 1,430 sh · avg $9.53 · $13,632
Loading xslF345X05/wk-form4_1772142963.xml…